Literature DB >> 25888648

LRRK2 mutations and neurotoxicant susceptibility.

Jang-Won Lee1, Jason R Cannon2.   

Abstract

Interactions between genetic and environmental factors are thought to contribute to the pathogenesis of the majority of Parkinson's disease (PD) cases. However, our understanding of these interactions is at an early stage. Mutations in leucine-rich repeat kinase 2 (LRRK2) are the most common cause of hereditary PD. Penetrance of LRRK2 mutations is incomplete and variable, suggesting that other environmental or genetic factors may contribute to the development of the disorder. Recently, using animal models, several attempts have been made to understand if LRRK2 may mediate sensitivity to environmental neurotoxicants. Here, we critically review the most current data on how LRRK2 mutations influence neurotoxicity in PD models.
© 2015 by the Society for Experimental Biology and Medicine.

Entities:  

Keywords:  Parkinson’s disease; gene–environment interaction; leucine-rich repeat kinase 2

Mesh:

Substances:

Year:  2015        PMID: 25888648      PMCID: PMC4935210          DOI: 10.1177/1535370215579162

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN: 1535-3699


  68 in total

Review 1.  Parkinson's disease: genetics and pathogenesis.

Authors:  Joshua M Shulman; Philip L De Jager; Mel B Feany
Journal:  Annu Rev Pathol       Date:  2011       Impact factor: 23.472

2.  Differential LRRK2 expression in the cortex, striatum, and substantia nigra in transgenic and nontransgenic rodents.

Authors:  Andrew B West; Rita M Cowell; João P L Daher; Mark S Moehle; Kelly M Hinkle; Heather L Melrose; David G Standaert; Laura A Volpicelli-Daley
Journal:  J Comp Neurol       Date:  2014-04-12       Impact factor: 3.215

3.  The role of SNCA and MAPT in Parkinson disease and LRRK2 parkinsonism in the Tunisian Arab-Berber population.

Authors:  J Trinh; E K Gustavsson; I Guella; C Vilariño-Güell; D Evans; M Encarnacion; H Sherman; F Hentati; M J Farrer
Journal:  Eur J Neurol       Date:  2014-11       Impact factor: 6.089

Review 4.  Genetic animal models of Parkinson's disease.

Authors:  Ted M Dawson; Han Seok Ko; Valina L Dawson
Journal:  Neuron       Date:  2010-06-10       Impact factor: 17.173

5.  LRRK2 controls synaptic vesicle storage and mobilization within the recycling pool.

Authors:  Giovanni Piccoli; Steven B Condliffe; Matthias Bauer; Florian Giesert; Karsten Boldt; Silvia De Astis; Andrea Meixner; Hakan Sarioglu; Daniela M Vogt-Weisenhorn; Wolfgang Wurst; Christian Johannes Gloeckner; Michela Matteoli; Carlo Sala; Marius Ueffing
Journal:  J Neurosci       Date:  2011-02-09       Impact factor: 6.167

6.  Enhanced striatal dopamine transmission and motor performance with LRRK2 overexpression in mice is eliminated by familial Parkinson's disease mutation G2019S.

Authors:  Xianting Li; Jyoti C Patel; Jing Wang; Marat V Avshalumov; Charles Nicholson; Joseph D Buxbaum; Gregory A Elder; Margaret E Rice; Zhenyu Yue
Journal:  J Neurosci       Date:  2010-02-03       Impact factor: 6.167

7.  Leucine-Rich Repeat Kinase 2 interacts with Parkin, DJ-1 and PINK-1 in a Drosophila melanogaster model of Parkinson's disease.

Authors:  Katerina Venderova; Ghassan Kabbach; Elizabeth Abdel-Messih; Yi Zhang; Robin J Parks; Yuzuru Imai; Stephan Gehrke; Johnny Ngsee; Matthew J Lavoie; Ruth S Slack; Yong Rao; Zhuohua Zhang; Bingwei Lu; M Emdadul Haque; David S Park
Journal:  Hum Mol Genet       Date:  2009-08-19       Impact factor: 6.150

8.  Phosphorylation of 4E-BP by LRRK2 affects the maintenance of dopaminergic neurons in Drosophila.

Authors:  Yuzuru Imai; Stephan Gehrke; Hua-Qin Wang; Ryosuke Takahashi; Kazuko Hasegawa; Etsuro Oota; Bingwei Lu
Journal:  EMBO J       Date:  2008-08-14       Impact factor: 11.598

9.  Mutant LRRK2(R1441G) BAC transgenic mice recapitulate cardinal features of Parkinson's disease.

Authors:  Yanping Li; Wencheng Liu; Tinmarla F Oo; Lei Wang; Yi Tang; Vernice Jackson-Lewis; Chun Zhou; Kindiya Geghman; Mikhail Bogdanov; Serge Przedborski; M Flint Beal; Robert E Burke; Chenjian Li
Journal:  Nat Neurosci       Date:  2009-06-07       Impact factor: 24.884

10.  Inhibitors of leucine-rich repeat kinase-2 protect against models of Parkinson's disease.

Authors:  Byoung Dae Lee; Joo-Ho Shin; Jackalina VanKampen; Leonard Petrucelli; Andrew B West; Han Seok Ko; Yun-Il Lee; Kathleen A Maguire-Zeiss; William J Bowers; Howard J Federoff; Valina L Dawson; Ted M Dawson
Journal:  Nat Med       Date:  2010-08-22       Impact factor: 53.440

View more
  13 in total

Review 1.  The unlikely partnership between LRRK2 and α-synuclein in Parkinson's disease.

Authors:  Noémie Cresto; Camille Gardier; Francesco Gubinelli; Marie-Claude Gaillard; Géraldine Liot; Andrew B West; Emmanuel Brouillet
Journal:  Eur J Neurosci       Date:  2018-10-24       Impact factor: 3.386

2.  Parkinson disease-associated LRRK2 G2019S transgene disrupts marrow myelopoiesis and peripheral Th17 response.

Authors:  Jeongho Park; Jang-Won Lee; Scott C Cooper; Hal E Broxmeyer; Jason R Cannon; Chang H Kim
Journal:  J Leukoc Biol       Date:  2017-07-27       Impact factor: 4.962

3.  Trichloroethylene, a ubiquitous environmental contaminant in the risk for Parkinson's disease.

Authors:  Briana R De Miranda; J Timothy Greenamyre
Journal:  Environ Sci Process Impacts       Date:  2020-01-30       Impact factor: 4.238

4.  Mutant LRRK2 mediates peripheral and central immune responses leading to neurodegeneration in vivo.

Authors:  Elena Kozina; Shankar Sadasivan; Yun Jiao; Yuchen Dou; Zhijun Ma; Haiyan Tan; Kiran Kodali; Timothy Shaw; Junmin Peng; Richard J Smeyne
Journal:  Brain       Date:  2018-06-01       Impact factor: 15.255

5.  Integrated analysis of differential expression and alternative splicing of non-small cell lung cancer based on RNA sequencing.

Authors:  Zulei Li; Kai Zhao; Hui Tian
Journal:  Oncol Lett       Date:  2017-06-02       Impact factor: 2.967

Review 6.  Behavioral Phenotyping and Pathological Indicators of Parkinson's Disease in C. elegans Models.

Authors:  Malabika Maulik; Swarup Mitra; Abel Bult-Ito; Barbara E Taylor; Elena M Vayndorf
Journal:  Front Genet       Date:  2017-06-13       Impact factor: 4.599

7.  The Air We Breathe: Air Pollution as a Prevalent Proinflammatory Stimulus Contributing to Neurodegeneration.

Authors:  Monika Jankowska-Kieltyka; Adam Roman; Irena Nalepa
Journal:  Front Cell Neurosci       Date:  2021-06-24       Impact factor: 5.505

8.  Parkinson disease risks: correctly identifying environmental factors for a chronic disease.

Authors:  Karl Kieburtz; E Ray Dorsey
Journal:  J Clin Invest       Date:  2021-06-01       Impact factor: 19.456

9.  A LUHMES 3D dopaminergic neuronal model for neurotoxicity testing allowing long-term exposure and cellular resilience analysis.

Authors:  L Smirnova; G Harris; J Delp; M Valadares; D Pamies; H T Hogberg; T Waldmann; M Leist; T Hartung
Journal:  Arch Toxicol       Date:  2015-12-08       Impact factor: 5.153

10.  Fluctuation Imaging of LRRK2 Reveals that the G2019S Mutation Alters Spatial and Membrane Dynamics.

Authors:  Bethany J Sanstrum; Brandee M S S Goo; Diana Z Y Holden; Donovan D Delgado; Thien P N Nguyen; Kiana D Lee; Nicholas G James
Journal:  Molecules       Date:  2020-05-31       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.